Pfizer To Use Russia's BIND Therapeutics Technology To Develop Drugs
This article was originally published in PharmAsia News
Executive Summary
Russia's BIND Therapeutics and Pfizer have signed an agreement for joint development and marketing of new drugs for treating cancers and other diseases.